CALMARE THERAPEUTICS Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.6M

196 transactions

Summary

CALMARE THERAPEUTICS Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $382KSales: $33K21 insiders

Date	Insider	Type	Value
2018-02-12	Brennan Peter F	C	$247K
2018-02-12	Brennan Peter F	C	$245K
2018-02-12	Brennan Peter F	C	$184K
2018-02-12	Brennan Peter F	C	$99K
2018-02-12	Mir Conrad F(President & CEO)	M	$80K
2018-02-12	Mir Conrad F(President & CEO)	M	$80K
2018-02-12	Brennan Peter F	C	$74K
2018-02-12	Richtarich Thomas Philip(Chief Financial Officer)	A	$30K
2018-02-12	Brennan Peter F	M	—
2015-01-02	Brennan Peter F	A	$0
2015-01-02	Brennan Peter F	A	$0
2015-01-02	MOUSSA ROBERT G	A	$0
2015-01-02	MOUSSA ROBERT G	A	$0
2015-01-02	YARBRO STAN	A	$0
2015-01-02	YARBRO STAN	A	$0
2015-01-02	HOWARD RUSTIN R	A	$0
2015-01-02	HOWARD RUSTIN R	A	$0
2014-01-31	MOUSSA ROBERT G	A	$0
2014-01-31	Brennan Peter F	A	$0
2014-01-02	MOUSSA ROBERT G	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

CALMARE THERAPEUTICS Inc — Contributions, Lobbying & Contracts | Poliscope